SCHEMBL20149961

SCHEMBL20149961

CC(C)(C)c1ccc(-c2nc3nc(n2)-c2cccc(c2)-c2nc(-c4ccccc4)nc(n2)-c2cccc(c2)-c2cccc-3c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.53
NPC1 O15118 1/20 0.53
ABCG2 Q9UNQ0 2/20 0.49
DHODH Q02127 1/20 0.49
TP53 P04637 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
RXRA P19793 2/20 0.46
RXRB P28702 2/20 0.46
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
MAPT P10636 3/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
KIF11 P52732 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
GLA P06280 1/20 0.42
ASIC1 P78348 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20089425 0.98 RAB9A (0.51) RAB9ANPC1ABCG2DHODHTP53
SCHEMBL13171479 0.93 NPC1 (0.52) RAB9ANPC1ABCG2DHODHTP53
SCHEMBL12628221 0.91 RAB9A (0.62) RAB9ANPC1ABCG2TP53SMN1; SMN2
SCHEMBL13539895 0.91 RAB9A (0.62) RAB9ANPC1ABCG2TP53SMN1; SMN2
SCHEMBL27252303 0.90 RXRA (0.45) RAB9ANPC1ABCG2DHODHTP53
SCHEMBL20089426 0.90 RXRA (0.59) RAB9ANPC1ABCG2DHODHTP53
SCHEMBL18627668 0.89 MEN1 (0.47) RAB9ANPC1ABCG2DHODHTP53
SCHEMBL12938318 0.89 RAB9A (0.60) RAB9ANPC1ABCG2TP53SMN1; SMN2
SCHEMBL19862786 0.89 RAB9A (0.60) RAB9ANPC1ABCG2TP53SMN1; SMN2
SCHEMBL13539886 0.89 RAB9A (0.60) RAB9ANPC1ABCG2TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10964893-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-03-30 US disclosed
US-20180138419-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed
US-20180138419-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180138419-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, SLCO4C1 RAB9A 3162/4885NPC1 927/4885ABCG2 682/4885
US-10964893-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, SLCO4C1 RAB9A 3162/4885NPC1 927/4885ABCG2 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.